PainTrain-AI Pilot: Feasibility, Usability (SUS) and Concept-Shift in Primary Care and a Specialized Setting
PT-AI Pilot
Feasibility and Usability of a Digital Clinical Simulation (PainTrain AI) for Chronic Pain Training in Health Professionals: A Multicenter Pilot in Primary Care (ICS) and a Specialized Comparative Setting
1 other identifier
interventional
40
1 country
1
Brief Summary
This pilot will assess feasibility and usability (SUS) and explore concept shift (reduction of neurophysiology misconceptions) after exposure to a behavioral educational intervention (PainTrain AI), a digital clinical simulation "fenced" by evidence (RAG) for safe, non diagnostic training. The study will be conducted in Primary Care and in a specialized comparative setting, without patient data collection. Primary endpoint: SUS score. Secondary endpoints: concept shift, adherence to micromodules, and interaction latency as friction metric. The platform does not generate clinical advice; it retrieves validated teaching content.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2027
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
Study Completion
Last participant's last visit for all outcomes
September 1, 2028
April 2, 2026
March 1, 2026
1 year
March 23, 2026
March 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Usability (SUS, 0-100)
Usability will be assessed using the System Usability Scale (SUS), a validated 10-item questionnaire that yields a score from 0 to 100. Higher scores indicate better usability. Participants will complete the SUS after interacting with the PainTrain-AI educational simulation for the predefined training period. The primary feasibility criterion is achieving a mean SUS score ≥75, indicating good usability.
4-8 weeks after onboarding
Secondary Outcomes (3)
Concept Shift
4-8 weeks.
Adherence
4-8 weeks
Latency/friction
4-8 weeks
Study Arms (1)
PainTrain-AI Behavioral Training
EXPERIMENTALParticipants in this arm will receive the behavioral educational intervention PainTrain-AI, a digital clinical simulation that uses a retrieval-augmented generation (RAG) safety architecture to deliver evidence-based teaching content. The platform provides simulated dialogues with virtual standardized patients to train biopsychosocial reasoning about chronic pain. All participants receive the same intervention; there is no control group.
Interventions
PainTrain-AI is a behavioral educational intervention delivered through a digital clinical simulation platform. The system uses a retrieval-augmented generation (RAG) safety architecture to ensure that all responses are generated only from validated pedagogical content. Participants engage in simulated dialogues with virtual standardized patients to practice biopsychosocial reasoning about chronic pain. The intervention is non-diagnostic, does not provide clinical advice, and does not involve patient data. All participants receive the same intervention.
Eligibility Criteria
You may qualify if:
- Health professionals in Primary Care (medicine, physiotherapy, nursing, psychology, nutrition) and specialized setting; willingness to use the platform; institutional approval.
You may not qualify if:
- lack of institutional access; unavailability during pilot window
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitat de Lleida
Lleida, Lleida, 25198, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Fran Valenzuela-Pascual, Dr.
Institut de Recerca Biomèdica de Lleida (IRBLleida) / Universitat de Lleida (UdL)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- This is an open-label feasibility study. No masking is applied. All participants receive the same behavioral educational intervention, and the study does not involve patient data or clinical outcomes that require blinded assessment.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 23, 2026
First Posted
March 27, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
No IPD will be shared because the study does not involve patient data or clinical individual-level information. Only anonymized usage datasets and aggregated concept-shift scores may be shared according to a FAIR plan (anonymized logs + codebooks), deposited in public repositories after embargo per grant policy.